Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT03003520
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2016-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-22
First Submit QC Date:
None
Study First Post Date:
2016-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-02
Results First Submit QC Date:
None
Results First Post Date:
2019-09-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-24
Last Update Post Date:
2023-05-22
Last Update Post Date Type:
ACTUAL